Tolvaptan for the treatment of heart failure: a review of the literature

Author： Ambrosy Andrew Goldsmith Steven R Gheorghiade Mihai

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.6, 2011-04, pp. : 961-976

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolvaptan a possible adjunct treatment for heart failure

Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Tolvaptan Offers an Alternative to Diuretics for Congestive Heart Failure

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 1, 2004-05 ,pp. : 23-25

Adis International

Access to resources Recommend Favorite

V₂ receptor antagonism with tolvaptan in heart failure

By Costello-Boerrigter Lisa C Boerrigter Guido Burnett John C

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1639-1647

Informa Healthcare

Access to resources Recommend Favorite

Clinical treatment regimens for chronic heart failure: a review

By Gould Paul A Kaye David M

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 11, 2002-11 ,pp. : 1569-1576

Informa Healthcare

Access to resources Recommend Favorite

A Review of Chinese Herbal Medicine for the Treatment of Chronic Heart Failure

Current Pharmaceutical Design, Vol. 23, Iss. 34, 2018-01 ,pp. : 5115-5124

Bentham Science Publishers

Access to resources Recommend Favorite